ORIC Stock Analysis: Buy, Sell, or Hold?
ORIC - Oric Pharmaceuticals, Inc. Common Stock
$8.49
-0.14 (-1.62%)
▼
5d:
+8.57%
30d:
+6.52%
90d:
-23.51%
BUY
HIGH Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Smart Money Accumulation
None View Scanner →
Strength: 4.2/10
Get Alerted When ORIC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ORIC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ORIC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: ORIC is currently trading at $8.49, which is considered slightly high relative to its 30-day fair value range of $7.84 to $8.66.
Technical Outlook: Technically, ORIC is in a strong downtrend. Immediate support is located at $7.36, while resistance sits at $8.98.
Market Sentiment: ORIC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.29 (+138.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ORIC is in a strong downtrend. Immediate support is located at $7.36, while resistance sits at $8.98.
Market Sentiment: ORIC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.29 (+138.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$7.84 -
$8.66
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 138.9% below Wall St target ($20.29)
Trading Range Analysis
30-Day Trading Range
$7.84 -
$8.66
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$7.36
Resistance Level
$8.98
Current Trend
Strong Downtrend
Technical data as of
Jun 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.39
Wall Street Target
$20.29
(+138.9%)
Share & Embed Analysis
Last updated: June 20, 2026 11:38 PM ET
Data refreshes hourly during market hours. Next update: 12:38 AM
Data refreshes hourly during market hours. Next update: 12:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORIC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Dominic Piscitelli
SELL
52000 shares
2026-02-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 60 BUY |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 51 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$198 | 58 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
